Transforming post pandemic cancer services.
Journal
British journal of cancer
ISSN: 1532-1827
Titre abrégé: Br J Cancer
Pays: England
ID NLM: 0370635
Informations de publication
Date de publication:
15 Mar 2024
15 Mar 2024
Historique:
received:
22
10
2022
accepted:
19
01
2024
revised:
15
11
2023
medline:
16
3
2024
pubmed:
16
3
2024
entrez:
16
3
2024
Statut:
aheadofprint
Résumé
This paper outlines the impact of the COVID-19 pandemic on cancer services in the UK including screening, symptomatic diagnosis, treatment pathways and projections on clinical outcomes as a result of these care disruptions. A restoration of cancer services to pre-pandemic levels is not likely to mitigate this adverse impact, particularly with an ageing population and increased cancer burden. New cancer cases are projected to rise to over 500,000 per year by 2035, with over 4 million people living with and beyond cancer. This paper calls for a strategic transformation to prioritise effort on the basis of available datasets and evidence-in particular, to prioritise cancers where an earlier diagnosis is feasible and clinically useful with a focus on mortality benefit by preventing emergency presentations by harnessing data and analytics. This could be delivered by a focus on underperforming groups/areas to try and reduce inequity, linking near real-time datasets with clinical decision support systems at the primary and secondary care levels, promoting the use of novel technologies to improve patient uptake of services, screening and diagnosis, and finally, upskilling and cross-skilling healthcare workers to expand supply of diagnostic and screening services.
Identifiants
pubmed: 38491174
doi: 10.1038/s41416-024-02596-9
pii: 10.1038/s41416-024-02596-9
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : DH | NIHR | Research Trainees Coordinating Centre (NIHR Research Trainees Coordinating Centre)
ID : DRF-2016-09-054
Informations de copyright
© 2024. The Author(s).
Références
Mountain of almost 50,000 people still missing a cancer diagnosis in the UK as NHS already struggling to cope with existing demand, November 26,2021, Macmillan press release, https://medium.com/macmillan-press-releases-and-statements/mountain-of-almost-50-000-people-still-missing-a-cancer-diagnosis-in-the-uk-as-nhs-already-f533f178cef3 and The Forgotten ‘C’? The impact of Covid-19 on cancer care – Macmillan cancer support, October 2020, https://www.macmillan.org.uk/assets/forgotten-c-impact-of-covid-19-on-cancer-care.pdf .
Armitage RC, Morling JR. The impact of COVID-19 on national screening programmes in England. Public Health. 2021;198:174–6. https://doi.org/10.1016/j.puhe.2021.07.022 .
doi: 10.1016/j.puhe.2021.07.022
pubmed: 34461451
Round T, Ashworth M, L’Esperance V, Møller H. Cancer detection via primary care urgent referral and association with practice characteristics: a retrospective cross-sectional study in England from 2009/2010 to 2018/2019. Br J Gen Pract. 2021;71:e826–35.
doi: 10.3399/BJGP.2020.1030
pubmed: 34544690
pmcid: 8463132
Round T, Gildea C, Ashworth M, Møller H. Association between use of urgent suspected cancer referral and mortality and stage at diagnosis: a 5-year national cohort study. Br J Gen Pract. 2020;70:e389–98.
doi: 10.3399/bjgp20X709433
pubmed: 32312762
pmcid: 7176359
Nicholson BD, Ordóñez-Mena JM, Lay-Flurrie S, et al. Consultations for clinical features of possible cancer and associated urgent referrals before and during the COVID-19 pandemic: an observational cohort study from English primary care. Br J Cancer. 2021. https://doi.org/10.1038/s41416-021-01666-6 .
doi: 10.1038/s41416-021-01666-6
pubmed: 34934176
pmcid: 8691390
NHS. Cancer Waiting Times Annual Report, 2020-21 NHS England, 8 July 2021 https://www.england.nhs.uk/statistics/statistical-work-areas/cancer-waiting-times/cwt-annual-reports/cancer-waiting-times-annual-report-2020-21/ .
Health.org.uk. Unfinished business: an assessment of the national approach to improving cancer services in England 1995–2015, November 2018 https://www.health.org.uk/publications/unfinished-business .
Rutter MD, Brookes M, Lee TJ, Rogers P, Sharp L. Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis. Gut. 2021;70:537–43.
Jones D, Neal RD, Duffy SR, Scott SE, Whitaker KL, Brain K. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. Lancet Oncol. 2020;21:748–50.
doi: 10.1016/S1470-2045(20)30242-4
pubmed: 32359404
pmcid: 7251992
NHS backlog data analysis, June 2022 https://www.bma.org.uk/advice-and-support/nhs-delivery-and-workforce/pressures/nhs-backlog-data-analysis and Consultant-led Referral to Treatment Waiting Times Data 2020-21, October 2021 https://www.england.nhs.uk/statistics/statistical-work-areas/rtt-waiting-times/rtt-data-2020-21/ .
Lim KH, Murali K, Kamposioras K, Punie K, Oing C, O’Connor M, et al. The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II. ESMO Open. 2021;6:100199.
doi: 10.1016/j.esmoop.2021.100199
pubmed: 34217129
pmcid: 8256184
Lim KH, Murali K, Thorne E, Punie K, Kamposioras K, Oing C, et al. The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series. ESMO Open. 2022;7:100374.
doi: 10.1016/j.esmoop.2021.100374
pubmed: 35007996
Health and Social Care Committee Workforce burnout and resilience in the NHS and social care, Second Report of Session 2021–22. 2021. https://committees.parliament.uk/work/494/workforce-burnout-and-resilience-in-the-nhs-and-social-care/ .
Maringe C, Spicer J, Morris M, Purushotham A, Nolte E, Sullivan R, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. Lancet Oncol. 2020;21:1023–34.
doi: 10.1016/S1470-2045(20)30388-0
pubmed: 32702310
pmcid: 7417808
Sud A, Torr B, Jones ME, Broggio J, Scott S, Loveday C, et al. Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study. Lancet Oncol. 2020;21:1035–44.
doi: 10.1016/S1470-2045(20)30392-2
pubmed: 32702311
pmcid: 7116538
Purushotham A, Roberts G, Haire K, Dodkins J, Harvey-Jones E, Han L, et al. The impact of national non-pharmaceutical interventions (‘lockdowns’) on the presentation of cancer patients. Ecancermedicalscience. 2021;15:1180.
doi: 10.3332/ecancer.2021.1180
pubmed: 33777173
pmcid: 7987492
Iqbal MS, Uzzaman L, Fox H, Munro S, Kelly C. The impact of COVID‐19 on the presentation, stage and management of head and neck cancer patients: a real‐time assessment. Clin Otolaryngol. 2022;47:251.
doi: 10.1111/coa.13874
pubmed: 34651421
Nossiter J, Morris M, Parry MG, Sujenthiran A, Cathcart P, van der Meulen J, et al. Impact of the COVID‐19 pandemic on the diagnosis and treatment of men with prostate cancer. BJU Int. 2022;130:262–70.
doi: 10.1111/bju.15699
pubmed: 35080142
Round T, L’Esperance V, Bayly J, Brain K, Dallas L, Edwards JG, et al. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary. Br J Cancer. 2021;125:629–40.
doi: 10.1038/s41416-021-01361-6
pubmed: 33972746
pmcid: 8108433
PHE National Cancer registration & Analysis. Routes to diagnosis workbook 2006-2016. http://www.ncin.org.uk/publications/routes_to_diagnosis .
Cancer incidence for common cancers, cancer research UK, March 2020 https://www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/common-cancers-compared#ref- and Cancer Mortality statistics, Cancer Research UK December 2020 https://www.cancerresearchuk.org/health-professional/cancer-statistics/mortality . Data were provided by the National Cancer Registration and Analysis Service (part of Public Health England), on request through the Office for Data Release, July 2021.
Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer incidence and mortality projections in the UK until 2035. Br J Cancer. 2016;115:1147–55.
doi: 10.1038/bjc.2016.304
pubmed: 27727232
pmcid: 5117795
Laudicella M, Walsh B, Burns E, Li Donni P, Smith PC. What is the impact of rerouting a cancer diagnosis from emergency presentation to GP referral on resource use and survival? Evidence from a population-based study. BMC Cancer. 2018;18:1–9.
doi: 10.1186/s12885-018-4274-0
Office for Health Improvement & Disparities. Public health profiles. Demographics, screening and diagnostics, deprivation score indicator. 2023. https://fingertips.phe.org.uk/profile/cancerservices/data . Accessed May 2023.
Wardle J, von Wagner C, Kralj-Hans I, Halloran SP, Smith SG, McGregor LM, et al. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. Lancet. 2016;387:751–9.
doi: 10.1016/S0140-6736(15)01154-X
pubmed: 26680217
pmcid: 4761689
Thomas C, Mandrik O, Whyte S. Modelling cost-effective strategies for minimising socioeconomic inequalities in colorectal cancer screening outcomes in England. Prev Med. 2022;162:107131.
doi: 10.1016/j.ypmed.2022.107131
pubmed: 35803353
Abel GA, Mendonca SC, McPhail S, Zhou Y, Elliss-Brookes L, Lyratzopoulos G. Emergency diagnosis of cancer and previous general practice consultations: insights from linked patient survey data. Br J Gen Pract. 2017;67:e377–87.
doi: 10.3399/bjgp17X690869
pubmed: 28438775
pmcid: 5442953
Murchie P, Smith SM, Yule MS, Adam R, Turner ME, Lee AJ, et al. Does emergency presentation of cancer represent poor performance in primary care? Insights from a novel analysis of linked primary and secondary care data. Br J Cancer. 2017;116:1148–58.
doi: 10.1038/bjc.2017.71
pubmed: 28334728
pmcid: 5418447
Erridge S, Lyratzopoulos G, Renzi C, Millar A, Lee R. Rapid diagnostic centres and early cancer diagnosis. Br J Gen Pract. 2021;71(712):487–8.
Pearson C, Poirier V, Fitzgerald K, Rubin G, Hamilton W. Cross-sectional study using primary care and cancer registration data to investigate patients with cancer presenting with non-specific symptoms. BMJ Open. 2020;10:e033008.
doi: 10.1136/bmjopen-2019-033008
pubmed: 31924638
pmcid: 6955554
Kostopoulou O, Rosen A, Round T, Wright E, Douiri A, Delaney B. Early diagnostic suggestions improve accuracy of GPs: a randomised controlled trial using computer-simulated patients. Br J Gen Pract. 2015;65:e49–54.
doi: 10.3399/bjgp15X683161
pubmed: 25548316
Chima S, Reece JC, Milley K, Milton S, McIntosh JG, Emery JD. Decision support tools to improve cancer diagnostic decision making in primary care: a systematic review. Br J Gen Pract. 2019;69:e809–18.
doi: 10.3399/bjgp19X706745
pubmed: 31740460
pmcid: 6863677
Ford E, Edelman N, Somers L, Shrewsbury D, Lopez Levy M, Van Marwijk H, et al. Barriers and facilitators to the adoption of electronic clinical decision support systems: a qualitative interview study with UK general practitioners. BMC Med Inform Decis Mak. 2021;21:1–3.
doi: 10.1186/s12911-021-01557-z
Møller H, Coupland VH, Tataru D, Peake MD, Mellemgaard A, Round T, et al. Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients. Thorax 2018;73:530–7.
doi: 10.1136/thoraxjnl-2017-210710
pubmed: 29511056
Round T, Abel G. Seeing the wood and the trees: the impact of the healthcare system on variation in primary care referrals. BMJ Qual Saf. 2020;29:274–6.
doi: 10.1136/bmjqs-2019-010356
pubmed: 31822513
Uy C, Lopez J, Trinh-Shevrin C, Kwon SC, Sherman SE, Liang PS. Text messaging interventions on cancer screening rates: a systematic review. J Med Internet Res. 2017;19:e296.
doi: 10.2196/jmir.7893
pubmed: 28838885
pmcid: 5590008
Hirst Y, Lim AW. Acceptability of text messages for safety netting patients with low-risk cancer symptoms: a qualitative study. Br J Gen Pract. 2018;68:e333–41.
doi: 10.3399/bjgp18X695741
pubmed: 29581127
pmcid: 5916080
Laake JP, Vulkan D, Quaife SL, Hamilton WT, Martins T, Waller J, et al. Targeted encouragement of GP consultations for possible cancer symptoms: a randomised controlled trial. Br J Gen Pract. 2021;71:e339–46.
doi: 10.3399/bjgp20X713489
pubmed: 33875418
Kennedy MP, Cheyne L, Darby M, Plant P, Milton R, Robson JM, et al. Lung cancer stage-shift following a symptom awareness campaign. Thorax 2018;73:1128–36.
doi: 10.1136/thoraxjnl-2018-211842
pubmed: 29950525
Round T. Primary care and cancer: facing the challenge of early diagnosis and survivorship. Eur J Cancer Care. 2017;26:e12703.
doi: 10.1111/ecc.12703
NHS. Diagnostics recovery and renewal. Report of the Independent Review of Diagnostic Services for NHS England. 2020. https://www.england.nhs.uk/wp-content/uploads/2020/11/diagnostics-recovery-and-renewal-independent-review-of-diagnostic-services-for-nhs-england-2.pdf .
House of Commons, Health and Social Care Committee. Cancer Services. Twelfth Report of Session 2021–22. 2022. https://committees.parliament.uk/publications/9562/documents/161967/default/ .
Marlow LA, Schmeising-Barnes N, Brain K, Duncombe S, Robb KA, Round T, et al. Multi-cancer early detection tests for cancer screening: a behavioural science perspective. Lancet Oncol. 2022;23:837–9.
Walter FM, Thompson MJ, Wellwood I, Abel GA, Hamilton W, Johnson M, et al. Evaluating diagnostic strategies for early detection of cancer: the CanTest framework. BMC Cancer. 2019;19:586.
doi: 10.1186/s12885-019-5746-6
pubmed: 31200676
pmcid: 6570853
Herbert A, Gary GA, Winters S, McPhail S, Elliss-Brookes L, Lyratzopoulos G. Cancer diagnoses after emergency GP referral or A&E attendance in England: determinants and time trends in Routes to Diagnosis data, 2006–2015. Br J Gen Pract. 2019;69:e724–30.